功能性发作:对分类的范围审查和新的三轴模型建议
Christoph Stephan Dietze1, Tamar Chloé van Gorp2, Anne Marthe Meppelink1
1Stichting Epilepsie Instellingen Nederland (SEIN), the Netherlands.
Epilepsy & behavior : E&B
|May 27, 2025
概括
功能性发作 (FS),也被称为心理非发作,缺乏明确的分类. 本综述提出了一个新的3D模型,包括时间和演变,以更好地描述FS半理学.
科学领域:
- 神经学 神经学
- 临床神经科学 临床神经科学
- 精神病学是一个精神病学.
背景情况:
- 功能性发作 (FS),也称为精神性非发作或离散性发作,伴有各种发作事件.
- 现有的FS标志学分类方案缺乏全球共识.
- 需要进行系统审查,以巩固目前的理解,并指导未来的分类工作.
研究的目的:
- 识别和审查功能性症状学的拟议分类.
- 澄清不同FS分类方案的核心概念和元素.
- 辨别现有的FS分类系统之间的共同点和差异.
主要方法:
- 进行了对MEDLINE和Embase数据库的系统范围审查,直到2023年6月14日.
- 搜索术语包括功能性发作的同义词,语义学和分类.
- 从 593 份选的摘要中,包括了 38 项详细介绍 FS 语义学分类的研究.
主要成果:
- 现有的FS分类显示在电机和响应轴上的部分对齐.
- 出现了四个一致的类别:非运动 (正常/受损反应) 和小/超运动运动 (变量/受损反应).
- 定时和ictal进化被确定为2D模型中关键但未映射的特征.
结论:
- 目前的FS语义分类是不完整的.
- 提出了一个新的三维模型,结合了运动,响应能力和时间/进化.
- 这种3D模型提供了一个更全面的框架来描述个别的功能性发作表征学.
相关概念视频
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
834
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
834


